Detailed autoradiographic studies of the distribution and the excretion of the barbiturates have been reported by Cassano and others (1967) , Schechter and Roth (1967) and Saubermann and others (1975) . It is known that the long-term administration of barbiturates shortens sleeping time gradually (Remmer, 1962 (Remmer, , 1964 , because of the accelerated metabolism of the barbiturates in the liver, as a result of the induction of drug metabolizing enzymes (Takahata and Ariyoshi, 1971; Takahata, 1973) . In this study, macroautoradiography was used to study the distribution and excretion of 14 C-pentobarbitone in rats pretreated with phenobarbitone, a potent inducer of drug-metabolizing enzymes in hepatic microsomes and to compare the results with those obtained in untreated animals (Matsuoka and Kashima, 1966, 1967; Sato, 1974) .
MATERIALS AND METHODS
Male albino Wistar rats (mean body weight: 107 + 9 g) were divided into two groups, the induction group and the control group. For 3 days before the experiment, phenobarbitone was administered i.p. to the induction group in a dose of 80 mg.kg~1.day~1. The control group was pretreated with the same amount of normal saline. On the day before the experiment, food TSUNEHIKO was withheld and water only given to the rats in both groups.
Pentobarbitone-2-14 C (5-ethyl-5-[l-methylbutyl] barbituric-2-14 C-acid, Spec, activity: 5.0 mCi. mmol" 1 (45.2 mg. mCi" 1 )) prepared by New England Nuclear Corp. (Boston, Mass.) was diluted with pentobarbitone sodium and distilled water to make a solution of 100 |jiCi per 30 mg in 5 ml.
The solution was injected (5 ml. kg" 1 ) i.v. through the tail vein of each rat over 30 s. After injection, the sleeping behaviour of the rats was observed and at intervals of 1, 5, 20 and 70 min after injection they were frozen in a mixture of solid carbon dioxide and acetone (-78 °C) (the rats were anaesthetized with diethyl ether), using the modified version of Ullberg's technique (Ullberg, 1954 (Ullberg, , 1971 Ullberg and Ewaldsson, 1964; Matsuoka, 1969a, b; Sato and Abe, 1969a, b) . The frozen rats were fixed on a microtome with a paste of 7% CMC (Carboxy Methyl Cellulose sodium) and sectioned into 50-fxm thick slices by means of a Cryostat (Bright Co.). The slices were dried while in the frozen state (-15 °C for 3 days), covered with a protective 6-jj.m thick Lumirer film and placed in contact exposure with industrial x-ray film (Type N, manufactured by Sakura Co.) in a cool dark room for a further 7 days. The exposed films were developed in Sakura Acedol at 20 °C for 5 min and fixed with Sakura Acefix at 20 °C for 15 min. Once the films were completely dry, the photographic density of each rgan on the films was measured by use of a Sakura Densitometer (PDA-11). A Sakura Scanner (PDS-15) was used also to measure continuously the photographic density of the samples from head to tail.
RESULTS
All the rats were noted to be asleep immediately following the i.v. injection of 14 C-pentobarbitone. In the control group awakening was not observed 70 min after the injection, whereas in the induction BRITISH JOURNAL OF ANAESTHESIA group, awakening was observed 30 min after injection.
Control group
The autoradiogram taken after 1 min ( fig. 1 ) showed clearly that there was a greater uptake of carbon-14 in the cerebral cortex than in heart blood, while less carbon-14 was distributed to the small intestine and urine. After 5 min, carbon-14 concentration was greater in the brain than in heart blood. and was small in the small intestine although great in urine. Carbon-14 concentration in brain decreased gradually after 20 min and increased in urine. This trend was noted also on the autoradiogram taken 70 min after the i.v. injection.
Induction group
The carbon-14 concentration in the brain, greater than that in the blood in the heart at 1 min and 5 min after the injection, decreased after 20 min ( fig. 2) . The concentration of carbon-14 in the small intestine increased rapidly during the first 20 min after the administration of 14 C-pentobarbitone. In the control group carbon-14 distribution in adipose tissue remained high, but in the induction group, although it remained high for 5 min, it decreased gradually later to become slightly less than that in heart blood 70 min after injection.
The variations in photographic density in the main organs, when compared with heart blood, are shown in figures 3 and 4. In the brain, the control group maintained a greater carbon-14 concentration than in heart blood, whereas the induction group showed a high concentration at 1 and 5 min after i.v. injection only and a decreasing concentration at 20 and 70 min. The carbon-14 concentration of adipose tissue was high only at 20 and 70 min after injection in the control group, while in the induction group, the concentration, great at 1 and 5 min, decreased gradually thereafter. In the liver a similar pattern was observed in both groups: carbon-14 concentration was twice that in heart blood. The carbon-14 concentration in the small intestine in the control group increased gradually with time, becoming three times that in heart blood, while in the induction group, carbon-14 concentration in the small intestine increased rapidly, to reach a value five times that in heart blood by 70 min. Figure 5 shows a continuous photographic density pattern obtained by the Scanner 70 min after the i.v. injection in both the control and induction groups. In the control group a slightly higher carbon-14 concentration in the brain and a significantly higher concentration in the small intestine, compared with that in heart blood, could be observed in die samples taken 70 min after i.v. injection. On the contrary, a lesser carbon-14 concentration in the brain than that in heart blood was observed in the induction group, and the concentration in the small intestine was observed to be twice that of the control group. In both groups, the concentrations of carbon-14 in the urine were similar.
DISCUSSION
It is well known that the activity of those drugmetabolizing enzymes which exist in the hepatic microsomes is affected by pretreatment with various hormones, drugs, agricultural medicines, food additive agents and carcinogens (Takahata and Ariyoshi, 1971; Takahata, 1973) . For example, it has been reported by Remmer (1964) , Yaffe and colleagues (1966) and Thompson, Eddleston and Williams (1969) that the metabolism of hexobarbitone was enhanced by pretreatment with phenobarbitone. Pentobarbitone is a barbiturate with a duration of action between that of the ultrashort-acting barbiturates such as thiopentone and that of the long-acting barbiturates such as phenobarbitone.
The biological half-life of pentobarbitone in blood is reported to be 70 min for rats (Ioannides and Parke, 1973) . In mice Saubermann, Gallagher and HedleyWhyte (1974) and Saubermann and others (1975) reported that the loss and the return of the withdrawal response to pinprick occurred 1 min and 6.7 min respectively following the i.v. injection of pentobarbitone 40 mg/kg. In the present investigation animals were sacrificed at 1 min after the i.v. injection of pentobarbitone (to observe the distribution of the injected pentobarbitone and to determine the time to loss of the withdrawal response), at 5 min (to determine the time of return of the withdrawal response), at 70 min (to measure the half-life of the drug in the blood) and at 20 min (to observe the distribution of 14 C-pentobarbitone between 5 and 70 min). Immediately after the i.v. injection sleep was observed in all animals in the present study. This finding differed from that reported by Saubermann, Gallagher and Hedley-Whyte (1974) and can be explained by the fact that the drug was injected gradually in our experiment (over 30 s), whereas in Saubermann's study, the drug was given over 2 s. In addition, in Saubermann's experiment, the time to the return of the withdrawal response was 6.7 min, whereas waking was not observed in the control group even after 70 min. However, we measured the time to the spontaneous waking of the rats, whereas a pinprick was given in Saubermann's experiment. Goldstein and Aronow (1960) reported that, in rats, the concentration of thiopentone in the brain equilibrated immediately with that in the blood following an i.v. injection, and thus produced sleep. However, 2-3 min later, the thiopentone had been distributed to the adipose tissue throughout the body, resulting in a rapid decrease in concentration in the blood and in the brain simultaneously and waking ensued. On the other hand, pentobarbitone required 2-3 min for absorption into brain and to reach its concentration equilibrium between brain and blood. When the blood concentration began to decrease, a certain amount of pentobarbitone remained in the brain for a comparatively long time. It was concluded that these results were attributable mainly to a difference in the lipid solubility of both drugs in brain tissue (Goldstein and Aronow, 1960; Mark, 1963) . In the present study, a similar result was obtained in the control group when carbon-14 concentration remained high in the brain compared with the blood until 70 min after the i.v. injection.
In general, the activity of drugs administered to the body decreases gradually as a result of absorption, distribution, biotransformation and excretion. However, Goldstein and Aronow (1960) considered that recovery from pentobarbitone anaesthesia was a result, not of distribution into adipose tissue, as with thiopentone, but of a decrease in drug concentration in the brain, as a result of metabolism. Yoshimura (1973) reported that pentobarbitone was inactivated by oxidation of its alkyl group. It has been reported also that, following the administration of pentobarbitone, about 55% was metabolized, while about 45% was excreted unchanged in the urine. On the other hand, Thomas and others (1972) noted that following intra-abdominal administration of pentobarbitone 30 mg.kgr 1 in rats, a chromatogram of the metabolites in the blood 3 h after the administration showed the presence of 22.4% unidentified substances and 72% unchanged pentobarbitone, and there was no biotransformation of the pentobarbitone absorbed in the brain.
From the present study, it may be concluded that the awakening from pentobarbitone anaesthesia was caused by inactivation resulting from metabolism of the drug. It became evident that in the enzymeinduction group, where drug metabolism was enhanced in the liver by phenobarbitone, the concentration of pentobarbitone in the brain decreased significantly with time compared with that of the control group (fig. 3) . The two groups did not differ in their carbon-14 concentrations in the liver (fig. 4) , but the induction group showed a remarkably high concentration in the small intestine. The carbon-14 concentrations were similar in the livers of both groups because the liver contains inherently a great amount of blood. Matsuoka and Kashima (1967) reported that the blood content decreases in the following order: blood, lung, liver, kidney, adrenal gland, brown fat, spleen, bone marrow, heart muscle, bowel, testis, submaxillary gland, pancreas, skeletal muscle, thymus, brain, spinal cord, seminal vesicle.
The photographic density of the urine of the induction group showed a less rapid increase compared with that of the control group since, in the induction group, the excretion of pentobarbitone was caused mainly by an increased excretion in the bile and in the small intestine ( fig. 5 ). In the control group, waking had not occurred 70 min after the i.v. injection of pentobarbitone 30 mg.kg-1 since these animals had a greater carbon-14 concentration in the brain. On the other hand, in the induction group the carbon-14 concentration in the brain was low after 70 min and waking took place in 30 min.
We conclude that the decrease of carbon-14 concentration in the brain was the result of the decrease of carbon-14 concentration in the blood caused by metabolism in the liver and this was confirmed by autoradiographic measurements of the excretion of radioactive isotopes into the small intestine. Ullberg, S., Ewaldssonj B. (1964) . Distribution of radioiodine studied by whole-body autoradiography. Acta Radiol. Ther. Phys. Biol., 2, 24. Yaffe, S. J., Levy, G., Matsuzawa, T., and Baliah, T. (1966 
SUMARIO
La distribuci6n y excretion de pentobarbitona fueron estudiados, empleando macroautoradiografia, en dos grupos de ratas a intervalos de entre 1 min a 70 min despu£s de la inyecci6n introvenosa de 100 (iCi, dada a 30 mg/kg de pentobarbitona-14 C. En un grupo de control, la concentration de carbono-14 (concentracion de pentobarbitona) en el cerebro permanecid en todo momento mayor que en la sangre del corazon (pentobarbitona no transformada y metabolitos). En un grupo sometido a induccion (pretratado con fenobarbitona), sin embargo, la concentration de carbono-14 en el cerebro excedio aquella en la sangre del coraz6n inicialmente, luego disminuyendo rapidamente. En el grupo inducido, la concentration de carbono-14 (la mayor parte de lo cual consistio de metabolitos) en la orina y en el intestino corto aumento con el paso del tiempo. En especial, 70 min despues de la inyeccion, la concentraci6n de carbono-14 en el intestino corto del grupo de inducci6n era doble de la del grupo de control. Se concluyd que en el grupo de induccion, la rapida disminucion en la concentraci6n de carbono-14 en el cerebro se debio principalmente a un aumento en el trastorno metabolico de pentobarbitona en el higado.
